Website profile

www.pharmabiz.com

Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma stud

  • 40articles · 30d
  • 1+ day agolatest article
  • Aug 16, 2026earliest in window
  • 0%with images
  • 47avg words
articles per day
Categories
  • Medical 29
  • Economy, Business & Finance 18
  • Business & Industrial 17
  • Health & Wellness 16
  • Health 15
  • Finance & Business 8
  • Science & Technology 4
  • News 3

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

pharmabiz.com
pharmabiz.com > NewsDetails.aspx

Adneuris Therapeutics presents novel data on lead candidate, cebranopadol to treat moderate-to-severe acute pain at PAINWeek 2026

1+ day, 14+ hour ago   (249+ words) Monmouth Junction, New Jersey Saturday, Septembe... Adneuris Therapeutics presents novel data on lead candidate, cebranopadol to treat moderate-to-severe acute pain at PAINWeek 2026 Adneuris Therapeutics, a wholly owned subsidiary of Tris Pharma advancing a new kind of pain medicine, announced novel…...

Pharmabiz.com
pharmabiz.com > NewsDetails.aspx

KIMS, Mahadevapura with Boston Scientific, unveils Illumina 3D technology for advanced deep brain stimulation programming

3+ day, 22+ hour ago   (31+ words) Pharmabiz.com KIMS, Mahadevapura with Boston Scientific, unveils Illumina 3D technology for advanced deep brain stimulation programming...

Pharmabiz.com
pharmabiz.com > NewsDetails.aspx

RDCA asks members to prepare their technical infrastructure for complying DCA mandate on controlled drugs

1+ week, 3+ day ago   (31+ words) Pharmabiz.com RDCA asks members to prepare their technical infrastructure for complying DCA mandate on controlled drugs...

Pharmabiz.com
pharmabiz.com > NewsDetails.aspx

TMIV Imaging launches CLARION 64/128-Slice AI-driven CT System at India Health Expo 2026

1+ week, 4+ day ago   (29+ words) Pharmabiz.com TMIV Imaging launches CLARION 64/128-Slice AI-driven CT System at India Health Expo 2026...

Pharmabiz.com
pharmabiz.com > NewsDetails.aspx

PCI tightens academic and evaluation standards in revised M.Pharm regulations

1+ week, 5+ day ago   (21+ words) Pharmabiz.com PCI tightens academic and evaluation standards in revised M.Pharm regulations...

Pharmabiz.com
pharmabiz.com > PrintArticle.aspx

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

1+ week, 5+ day ago   (19+ words) Pharmabiz.com Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026...

Pharmabiz.com
pharmabiz.com > NewsDetails.aspx

RDCA directs retail chemists to comply with Delhi DC dept advisory on discount boards

2+ week, 4+ day ago   (29+ words) Pharmabiz.com RDCA directs retail chemists to comply with Delhi DC dept advisory on discount boards...

Pharmabiz.com
pharmabiz.com > NewsDetails.aspx

Maharashtra FDA to prioritise process audits for revised Schedule M compliance: FDA Commissioner

2+ week, 6+ day ago   (27+ words) Pharmabiz.com Maharashtra FDA to prioritise process audits for revised Schedule M compliance: FDA Commissioner...

Pharmabiz.com
pharmabiz.com > NewsDetails.aspx

Karnataka FDA???s prompt action in seizing spurious drugs worth Rs. 5 crore shows regulatory expertise: BDCDA

3+ week, 1+ day ago   (34+ words) Karnataka FDA’s prompt action in seizing spurious drugs worth Rs. 5 crore shows regulatory expertise: BDCDA Pharmabiz.com Karnataka FDA’s prompt action in seizing spurious drugs worth Rs. 5 crore shows regulatory expertise: BDCDA...

pharmabiz.com
pharmabiz.com > ArticleDetails.aspx

Chugai Pharma seeks additional indication approval from Japan for Tecentriq for adjuvant treatment of MSI-High colon cancer

3+ week, 6+ day ago   (99+ words) Tokyo Monday, August 17, 2026, 13:00 Hrs [IST] Chugai... Chugai Pharma seeks additional indication approval from Japan for Tecentriq for adjuvant treatment of MSI-High colon cancer Chugai Pharmaceutical Co., Ltd. announced that it has filed a regulatory application with the Ministry of Health,…...